U.S. flag

An official website of the United States government

NC_000009.11:g.(108484903_108510353)_(108538893_?)del AND Osteogenesis imperfecta

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Feb 14, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003155762.1

Allele description [Variation Report for NC_000009.11:g.(108484903_108510353)_(108538893_?)del]

NC_000009.11:g.(108484903_108510353)_(108538893_?)del

Gene:
TMEM38B:transmembrane protein 38B [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
9q31.2
Genomic location:
Chr9: 108484903 - 108538893 (on Assembly GRCh37)
Preferred name:
NC_000009.11:g.(108484903_108510353)_(108538893_?)del
HGVS:
NC_000009.11:g.(108484903_108510353)_(108538893_?)del

Condition(s)

Name:
Osteogenesis imperfecta (OI)
Identifiers:
MONDO: MONDO:0019019; MeSH: D010013; MedGen: C0029434; OMIM: PS166200

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV003844719Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Likely pathogenic
(Feb 14, 2023)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV003844719.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

Variant summary: The variant identified by MLPA or other technology involves the deletion of exons 5-6, which includes the last exon in the TMEM38B gene. The exact breakpoint at the 3' end of this variant is unknown, and therefore this deletion might extend downstream of the assayed region of the gene. A presumed nomenclature of c.(542+1_543-1)_(*2532_?)del has been designated for the purposes of this classification. Although exact breakpoints of this deletion are not known, it is not expected to cause nonsense mediated decay (NMD), but is predicted to cause a large truncation of the encoded protein (removing amino acids ~181-291, and likely replacing it with an incorrect sequence). The variant was absent in 21346 control chromosomes (gnomAD database, structural variants dataset). To our knowledge, no occurrence of c.(542+1_543-1)_(*2532_?)del in individuals affected with Osteogenesis Imperfecta and no experimental evidence demonstrating its impact on protein function have been reported. However, a large deletion variant overlapping with our variant of interest (i.e. exon 5 deletion) was reported in affected individual(s) (HGMD), which might indicate a functional importance for the deleted protein region. No submitters have provided clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as likely pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Apr 1, 2023